D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT. All of our product candidates are in clinical or preclinical development and have not yet ...

Before you leave, throw yourself a going-away party. Make it a “take all the stuff I can’t take with me to the city” theme ...

The founder's story, values, and voice have become as important, if not more , than the logo or the brand. Consumers are ...

The Windows logo of Microsoft has drastically changed from the time when it was first launched in 1985. With time, it has ...

Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the ...

LUXTURNA uses an adeno-associated viral type 2 (AAV2) vector to deliver the RPE65 gene ... In 2023, approximately 113,000 people in the US were affected by retinitis pigmentosa. Currently, available ...

Not only is it environmentally toxic, but also, when it is overused to treat people and animals with worm and parasite ... As an unintended benefit, extending the use of nitisinone as a vector control ...

Compared to nearby cities, Philly seems to have a much lower rat population, or at least is home to vermin who are better at ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The service allows people to send and receive text messages via satellite when they’re outside cellular range. Recipients can be on any network or device. The new feature is distinct from the ...

If you’ve heard about Careless People, the scandalous new memoir from former Facebook executive Sarah Wynn-Williams, it’s likely because you first heard about Meta’s relentless efforts to ...

A judge ruled that Elon Musk and DOGE's efforts to close USAID likely violate the Constitution in multiple ways. New York Times columnist Nicholas Kristof joins Ana Cabrera and shares more on the ...